» Articles » PMID: 24260139

The Landscape of Inappropriate Laboratory Testing: a 15-year Meta-analysis

Overview
Journal PLoS One
Date 2013 Nov 22
PMID 24260139
Citations 156
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Laboratory testing is the single highest-volume medical activity and drives clinical decision-making across medicine. However, the overall landscape of inappropriate testing, which is thought to be dominated by repeat testing, is unclear. Systematic differences in initial vs. repeat testing, measurement criteria, and other factors would suggest new priorities for improving laboratory testing.

Methods: A multi-database systematic review was performed on published studies from 1997-2012 using strict inclusion and exclusion criteria. Over- vs. underutilization, initial vs. repeat testing, low- vs. high-volume testing, subjective vs. objective appropriateness criteria, and restrictive vs. permissive appropriateness criteria, among other factors, were assessed.

Results: Overall mean rates of over- and underutilization were 20.6% (95% CI 16.2-24.9%) and 44.8% (95% CI 33.8-55.8%). Overutilization during initial testing (43.9%; 95% CI 35.4-52.5%) was six times higher than during repeat testing (7.4%; 95% CI 2.5-12.3%; P for stratum difference <0.001). Overutilization of low-volume tests (32.2%; 95% CI 25.0-39.4%) was three times that of high-volume tests (10.2%; 95% CI 2.6-17.7%; P<0.001). Overutilization measured according to restrictive criteria (44.2%; 95% CI 36.8-51.6%) was three times higher than for permissive criteria (12.0%; 95% CI 8.0-16.0%; P<0.001). Overutilization measured using subjective criteria (29.0%; 95% CI 21.9-36.1%) was nearly twice as high as for objective criteria (16.1%; 95% CI 11.0-21.2%; P = 0.004). Together, these factors explained over half (54%) of the overall variability in overutilization. There were no statistically significant differences between studies from the United States vs. elsewhere (P = 0.38) or among chemistry, hematology, microbiology, and molecular tests (P = 0.05-0.65) and no robust statistically significant trends over time.

Conclusions: The landscape of overutilization varies systematically by clinical setting (initial vs. repeat), test volume, and measurement criteria. Underutilization is also widespread, but understudied. Expanding the current focus on reducing repeat testing to include ordering the right test during initial evaluation may lead to fewer errors and better care.

Citing Articles

Rationalising blood tests in a resource-limited emergency unit: A quality improvement project.

Esterhuizen R, Tribelhorn L, Thomas D, Elliott E, Habib T, Nair A S Afr Fam Pract (2004). 2025; 67(1):e1-e5.

PMID: 39935160 PMC: 11886463. DOI: 10.4102/safp.v67i1.6067.


Optimizing laboratory medication safety monitoring in patients with juvenile idiopathic arthritis to advance value-based care.

Harris J, Holland M, Fox E, Favier L, Hoffart C, Ibarra M Clin Rheumatol. 2025; 44(3):1293-1297.

PMID: 39853558 DOI: 10.1007/s10067-025-07342-x.


Impact of Order Restrictions on Hemoglobin A1c Requests at Primary Health Care Centers in Riyadh, Saudi Arabia.

Alakeely M, Masud N, Bin Saleh F, Alghassab R, AlFagih N, Alkathiri M Risk Manag Healthc Policy. 2025; 18():95-104.

PMID: 39816785 PMC: 11734510. DOI: 10.2147/RMHP.S499918.


An Automated Clinical Laboratory Decision Support System for Test Utilization, Medical Necessity Verification, and Payment Processing.

Beqaj S, Shrestha R, Hamill T Interact J Med Res. 2025; 14:e46007.

PMID: 39808833 PMC: 11862781. DOI: 10.2196/46007.


Decreasing Unnecessary Resource Utilization for New-onset, Unprovoked, Afebrile Seizure in the Emergency Department.

Santry L, Giordano K, Mower A, Hubbard J, Thomas J, Scott R Pediatr Qual Saf. 2025; 10(1):e787.

PMID: 39802298 PMC: 11723707. DOI: 10.1097/pq9.0000000000000787.


References
1.
Miyakis S, Karamanof G, Liontos M, Mountokalakis T . Factors contributing to inappropriate ordering of tests in an academic medical department and the effect of an educational feedback strategy. Postgrad Med J. 2006; 82(974):823-9. PMC: 2653931. DOI: 10.1136/pgmj.2006.049551. View

2.
Pilsczek F, Rifkin W, Walerstein S . Overuse of prothrombin and partial thromboplastin coagulation tests in medical inpatients. Heart Lung. 2005; 34(6):402-5. DOI: 10.1016/j.hrtlng.2005.07.004. View

3.
Mann K, Hiemke C, Schmidt L, Bates D . Appropriateness of therapeutic drug monitoring for antidepressants in routine psychiatric inpatient care. Ther Drug Monit. 2006; 28(1):83-8. DOI: 10.1097/01.ftd.0000189897.16307.65. View

4.
Gandhi T, Kachalia A, Thomas E, Puopolo A, Yoon C, Brennan T . Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann Intern Med. 2006; 145(7):488-96. DOI: 10.7326/0003-4819-145-7-200610030-00006. View

5.
Canas F, Tanasijevic M, Maluf N, Bates D . Evaluating the appropriateness of digoxin level monitoring. Arch Intern Med. 1999; 159(4):363-8. DOI: 10.1001/archinte.159.4.363. View